A detailed history of Wetherby Asset Management Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Wetherby Asset Management Inc holds 101,581 shares of NVO stock, worth $10.7 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
101,581
Previous 104,424 2.72%
Holding current value
$10.7 Million
Previous $14.9 Million 18.85%
% of portfolio
0.57%
Previous 0.72%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.07 - $145.42 $338,516 - $413,429
-2,843 Reduced 2.72%
101,581 $12.1 Million
Q2 2024

Aug 14, 2024

SELL
$122.71 - $146.91 $66,386 - $79,478
-541 Reduced 0.52%
104,424 $14.9 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $64,635 - $86,037
633 Added 0.61%
104,965 $13.5 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $20,189 - $24,253
230 Added 0.22%
104,332 $10.8 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $4.82 Million - $10.6 Million
52,963 Added 103.57%
104,102 $9.47 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $64,887 - $71,822
416 Added 0.82%
51,139 $8.28 Million
Q1 2023

May 12, 2023

BUY
$132.34 - $159.14 $99,784 - $119,991
754 Added 1.51%
50,723 $8.07 Million
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $137,827 - $181,883
1,344 Added 2.76%
49,969 $6.76 Million
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $27,345 - $33,558
-287 Reduced 0.59%
48,625 $4.84 Million
Q2 2022

Aug 15, 2022

BUY
$103.24 - $121.81 $203,899 - $240,574
1,975 Added 4.21%
48,912 $5.45 Million
Q1 2022

May 16, 2022

BUY
$93.1 - $112.54 $108,554 - $131,221
1,166 Added 2.55%
46,937 $5.21 Million
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $119,082 - $145,413
1,242 Added 2.79%
45,771 $5.13 Million
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $72,179 - $91,160
855 Added 1.96%
44,529 $4.28 Million
Q2 2021

Aug 16, 2021

BUY
$67.66 - $84.76 $43,234 - $54,161
639 Added 1.48%
43,674 $3.66 Million
Q1 2021

May 14, 2021

BUY
$67.06 - $75.82 $50,898 - $57,547
759 Added 1.8%
43,035 $2.9 Million
Q4 2020

Feb 11, 2021

BUY
$63.89 - $73.8 $4,152 - $4,797
65 Added 0.15%
42,276 $2.95 Million
Q3 2020

Dec 16, 2020

SELL
$63.69 - $70.22 $24,074 - $26,543
-378 Reduced 0.89%
42,211 $2.93 Million
Q3 2020

Nov 13, 2020

BUY
$63.69 - $70.22 $3,120 - $3,440
49 Added 0.12%
42,589 $2.96 Million
Q2 2020

Aug 14, 2020

BUY
$58.54 - $67.94 $409,370 - $475,104
6,993 Added 19.67%
42,540 $2.79 Million
Q1 2020

May 06, 2020

BUY
$49.46 - $64.78 $95,902 - $125,608
1,939 Added 5.77%
35,547 $2.14 Million
Q4 2019

Jan 28, 2020

SELL
$49.86 - $58.26 $73,443 - $85,816
-1,473 Reduced 4.2%
33,608 $1.95 Million
Q3 2019

Oct 31, 2019

BUY
$47.54 - $53.43 $67,601 - $75,977
1,422 Added 4.22%
35,081 $1.81 Million
Q2 2019

Jul 25, 2019

BUY
$46.79 - $52.47 $54,369 - $60,970
1,162 Added 3.58%
33,659 $1.72 Million
Q1 2019

May 09, 2019

BUY
$46.36 - $52.63 $7,000 - $7,947
151 Added 0.47%
32,497 $1.7 Million
Q4 2018

Jan 30, 2019

BUY
$41.54 - $47.25 $23,553 - $26,790
567 Added 1.78%
32,346 $1.49 Million
Q3 2018

Nov 07, 2018

BUY
$46.76 - $51.24 $17,207 - $18,856
368 Added 1.17%
31,779 $1.5 Million
Q2 2018

Jul 24, 2018

SELL
$44.29 - $50.42 $34,634 - $39,428
-782 Reduced 2.43%
31,411 $1.45 Million
Q1 2018

May 04, 2018

BUY
$48.49 - $58.14 $20,414 - $24,476
421 Added 1.33%
32,193 $1.59 Million
Q4 2017

Feb 09, 2018

SELL
$47.53 - $53.73 $6,273 - $7,092
-132 Reduced 0.41%
31,772 $1.71 Million
Q3 2017

Nov 13, 2017

BUY
$41.15 - $49.22 $1.31 Million - $1.57 Million
31,904
31,904 $1.54 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wetherby Asset Management Inc Portfolio

Follow Wetherby Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.